Showing results (1691-1700 of 6,770) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|November 1, 1989
Treatment of chronic erosive gastritis: a double-blind trial of pirenzepine and cimetidineP R Dal Monte, N D'Imperio, A Barillari, et al.Clinical Therapeutics|November 1, 1989
Efficacy of a premixed semisynthetic human insulin regimenD S Bell, G R Cutter, A A LauritanoClinical Therapeutics|April 5, 2016
Patient-reported Symptom Experiences in Patients With Carcinoid Syndrome After Participation in a Study of Telotristat Etiprate: A Qualitative Interview ApproachHeather L Gelhorn, Matthew H Kulke, Thomas O'Dorisio, et al.Clinical Therapeutics|April 5, 2016
Genomic Alterations and Targeted Therapy in Gastric and Esophageal AdenocarcinomaEirini PectasidesClinical Therapeutics|April 6, 2016
Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical TrialsEthan Basch, Lauren J Rogak, Amylou C DueckClinical Therapeutics|March 22, 2016
Safety of the Up-titration of Nifedipine GITS and Valsartan or Low-dose Combination in Uncontrolled Hypertension: the FOCUS StudyJeong Bae Park, Joon-Han Shin, Dong-Soo Kim, et al.Clinical Therapeutics|November 8, 2017
Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9)Maria Yu, Kate Van Brunt, Zvonko Milicevic, et al.Clinical Therapeutics|November 8, 2017
Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European CountriesEdith M Heintjes, Jetty A Overbeek, Gillian C Hall, et al.Clinical Therapeutics|July 19, 2015
Evaluating the Cost of Bringing People with Type 2 Diabetes Mellitus to Multiple Targets of Treatment in CanadaRasmus Skovgaard, Uffe Jon Ploug, Barnaby Hunt, et al.Clinical Therapeutics|February 5, 2025
Real-World Effectiveness of Sotrovimab in Ambulatory Patients With COVID-19: A Retrospective Cohort Study Using a Large Administrative Claims Database in the United StatesChristopher F Bell, Tasneem Lokhandwala, Daniel C Gibbons, et al.Pageof 677